Bios Equity Partners II, LP

Bios Equity Partners II, LP is 10% Owner at Lantern Pharma Inc. (LTRN). They have made 2 open-market trades across 2 companies since 2022, most recently 2024-06-07.

CIK 0001813313

Get an email the next time Bios Equity Partners II, LP files.Follow for free

1 open-market purchase totalling $51K since 2022, against 1 sale. Too few scored purchases to measure a record yet.

Also files as

Controlled by BP Directors, LP

BP Directors, LP (entity)Bios Equity Partners II, LP (entity)

Current Position

Ticker	Shares	Value
INAB	574,241	$614K
LTRN	515,412	$337K
CGTX	14,500	$11K
Total		$962K

Shares reported on the most recent Form 4, priced at the 2024-06-11 close.

Grade by Ticker

CINAB

awaiting returns

Get an email the next time Bios Equity Partners II, LP files

Free account. One email when the next filing comes in.

Follow Bios Equity Partners II, LP for free

Buy Track Record

Filings1

Only 1 discretionary filing — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.

Sell Track Record

Filings1

Only 1 decision-sell filing — too few to score

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.